Navigation Links
Shockwave Lithotripsy is Effective for Pediatric Urolithiasis

Shockwave Lithotripsy has been found to be an efficacious modality for pediatric urolithiasis, according to a recent review.

The literature also shows that good results are obtained even with large stone// burdens, irrespective of stone location. Wadhwa, et al reviewed the outcomes of shockwave lithotripsy in the pediatric population in their center in New Delhi, India. They assessed the impact of stone burden and location, as well as the age of the child on the stone free rates.

They reviewed 106 patients who were less than 16 years of age treated with shockwave lithotripsy for stones with a surface area of 20-600 mm2 between July 1989 and June 2004. Metabolic abnormalities were present in 20.7% of the patients. All the procedures were performed using the Siemens Lithostar and the stone clearance was assessed 3 months after shockwave lithotripsy. Complications and the need for subsequent treatment and ancillary procedures were noted. The impacts of stone size and location as well as the age of the child were assessed regarding stone clearance.

The group found that the overall stone-free rate was 87% with a complete clearance of 72% and what they called an insignificant less than 3-mm residual fragments of 15%. The re-treatment rate was 58%. The efficiency quotient was 47. They also found that stone size correlated with a stone free rate while patient age and stone location did not have a significant impact.

The group concluded that shockwave lithotripsy is an effective modality to treat pediatric upper urinary tract calculi, especially when the stone burden is less than 200 mm2. Larger stone burdens are associated with a poorer clearance and required subsequent procedures. They also found hat the larger stone burdens had a higher complication rate. If shockwave lithotripsy is going to be used as a modality in stone treatment, it is our responsibility as the surgeons to follow these children long term to ensure that not only is it an efficacious modality but safe with no long term morbidity to the patients.

Source-Newswise
'"/>




Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... ... May 31, 2016 , ... Interest is on the rise ... and as an orthogonal tool for RNAi hit validation. A key reason may be ... RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. , ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview on The Greenburgh Report ... Rochelle, NY-based WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross ... “modern medical money maelstrom.” , During the interview with Mr. Feiner that aired ...
(Date:5/31/2016)... IL (PRWEB) , ... May 31, 2016 , ... ... multichannel marketing services firm and statement solutions provider, for the tenth ... in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth in ...
(Date:5/31/2016)... ... ... Super Powder, a supplement produced by Prox Formulas for providing protein ... to transform the nutritional supplement industry by providing a safe, natural approach to enhanced ... (BCAA), alkaline minerals, wheat grass, digestive enzymes, Omega 3’s, Vit D3, Vit A, B1, ...
(Date:5/30/2016)... ... May 30, 2016 , ... Zane Benefits, the leader ... an original infographic, " Health Benefits Reimbursement Compliance Timeline ." , The ... complies with various federal regulations and reforms. , Navigating the new health reforms ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology: